11 participants
Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-12-05
- Start Date:
- 2020-01-10
- Completion:
- 2022-10-18
Conditions
- Epidermolysis Bullosa
- Recessive Dystrophic Epidermolysis Bullosa
Interventions
- BIOLOGICAL
No Results Yet